BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2477934)

  • 1. Pharmacology and pharmacokinetics of flutamide.
    Neri R
    Urology; 1989 Oct; 34(4 Suppl):19-21; discussion 46-56. PubMed ID: 2477934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flutamide. Mechanism of action of a new nonsteroidal antiandrogen.
    Sufrin G; Coffey DS
    Invest Urol; 1976 May; 13(6):429-34. PubMed ID: 1270239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity.
    Luo S; Martel C; Chen C; Labrie C; Candas B; Singh SM; Labrie F
    Urology; 1997 Dec; 50(6):913-9. PubMed ID: 9426723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-androgenic activity of various substituted carboxyanilides].
    Varga SV; Reznikov AG; Bal'on IaG; Lozinskiĭ MO; Smirnov VA
    Probl Endokrinol (Mosk); 1983; 29(2):67-71. PubMed ID: 6856597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alpha, alpha, alpha-trifluoro-2-methyl-4'-nitro-m-lactotoluidide (Sch 16423) on serum testosterone and LH in rats.
    Clark CR; Merry BJ; Nowell NW
    J Reprod Fertil; 1981 Jan; 61(1):189-91. PubMed ID: 7452616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-androgenicity of flutamide and its metabolite Sch 16423.
    Neri R; Peets E; Watnick A
    Biochem Soc Trans; 1979 Jun; 7(3):565-9. PubMed ID: 446862
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of antiandrogens in the rat.
    Burton S; Trachtenberg J
    J Urol; 1986 Oct; 136(4):932-5. PubMed ID: 3761464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
    Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
    Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological aspects of antiandrogens.
    Neri RO; Peets EA
    J Steroid Biochem; 1975 Jun; 6(6):815-9. PubMed ID: 1177425
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental anti-androgenic activity of 4-nitro-3-trifluoromethylisobutyranilide (niftholide) in rats and guinea pigs].
    Reznikov AG; Varga SV; Demkiv LP; Bal'on IaG; Iagupol'skiĭ LM
    Farmakol Toksikol; 1977; 40(3):336-42. PubMed ID: 902725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the 5 alpha-reductase inhibitor PNU 156765, alone or in combination with flutamide, in the Dunning R3327 prostatic carcinoma model in rats.
    Zaccheo T; Giudici D; Panzeri A; di Salle E
    Chemotherapy; 1998; 44(4):284-92. PubMed ID: 9681205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of hypertrophy of the prostate of rats with 4-nitro-3-trifluoromethylisobutyranilide (Sch 13521).
    Syrkin AB; Smirnova IO; Lazarev NI
    Arzneimittelforschung; 1977 Jul; 27(7):1467-9. PubMed ID: 71154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antiandrogenic effect of dimethachlon and its mechanism].
    Zhang GJ; Zheng YF; Zhu HJ; Zhu XQ
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Feb; 22(1):15-8. PubMed ID: 15033008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate.
    Shibata Y; Ono Y; Kashiwagi B; Suzuki K; Fukabori Y; Honma S; Yamanaka H
    Urology; 2003 Nov; 62(5):942-6. PubMed ID: 14624931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity.
    Yamada T; Kunimatsu T; Sako H; Yabushita S; Sukata T; Okuno Y; Matsuo M
    Toxicol Sci; 2000 Feb; 53(2):289-96. PubMed ID: 10696777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyproterone acetate in comparison to flutamide and megestrol acetate on the ventral prostate, seminal vesicle, and adrenal glands of adult male rats.
    el Etreby MF; Habenicht UF; Louton T; Nishino Y; Schröder HG
    Prostate; 1987; 11(4):361-75. PubMed ID: 2960960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
    Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
    Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine profile of Win 49596 in the rat: a novel androgen receptor antagonist.
    Snyder BW; Winneker RC; Batzold FH
    J Steroid Biochem; 1989 Dec; 33(6):1127-32. PubMed ID: 2615357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flutamide inhibits testosterone-induced masculine sexual behavior in male and female rats.
    Gladue BA; Clemens LG
    Endocrinology; 1980 Jun; 106(6):1917-22. PubMed ID: 7371596
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diethylstilbestrol potentiation of the antiandrogenic effects of niftolide in the prostate].
    Sinitsyn PV; Varga SV; Reznikov AG
    Farmakol Toksikol; 1988; 51(4):75-7. PubMed ID: 3191980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.